Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Veronika Franekova"'
Aims: Limb-girdle muscular dystrophy R9 (LGMDR9) is an autosomal recessive disorder caused by mutations in the fukutin-related protein gene (FKRP), encoding a glycosyltransferase involved in α-dystroglycan modification. Muscle atrophy, a significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0e662807c434ae04d60b8481ceb1884
https://hdl.handle.net/10037/25267
https://hdl.handle.net/10037/25267
Autor:
Veronika Franekova, Darrell D. Belke, Wahida Salma, Kirsti Ytrehus, Stian Ludvigsen, Ellen Aasum, Anje Christina Höper, Jim Lund, Terje S. Larsen, Trine Lund
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids. 108
Background We have recently shown that Calanus oil, which is extracted from the marine copepod Calanus finmarchicus , reduces fat deposition, suppresses adipose tissue inflammation and improves insulin sensitivity in high fat-fed rodents. This study
Publikováno v:
Neurochemistry international. 55(5)
Cytosolic regions of sodium dependent neurotransmitter transporters regulate their surface density and transporting function by interconnecting themselves with intracellular signaling pathways. Here we show that calpain activation in rat brain synapt
Publikováno v:
Neurochemistry international. 52(8)
It has been shown recently that the N-terminal domain of the dopamine transporter (DAT) plays a role in several transporter functions. Here we provide evidence for a possible cellular mechanism of how the N-terminus of dopamine transporter might be r
Autor:
Daniel C. Chan, Samir E. Witta, Xiaomei Sui, Peter Ordentlich, Di Zheng, Veronika Franekova, Fred R. Hirsch, Paul A. Bunn
Publikováno v:
Cancer Research. 70:5439-5439
Background: Entinostat is a novel oral benzamide HDACi characterized by its selectivity for class 1 HDACs as well as a unique pharmacokinetic (PK) and pharmacodynamic (PD) profile. Previous results have demonstrated the ability of entinostat to syner